Thursday, November 12, 2026

BTC $69,889 ▼ 2.08%

NewsLive Wire Politics World Markets Digital Assets Technology Sports

FranchisesThe Brief The Big Read The Breakdown Crypto Culture

MoreDeFi & On-Chain U.S. Equities Macro & Rates Research

LIVE

ADA$0.171−1.62%ETH$1,983−1.72%LINK$9.91−2.27%SOL$79.94−2.06%BTC$69,889−2.08%XRP$1.02−2.32%S&P 5007,592−0.35%Nasdaq25,366−0.39%Dow52,297−0.36%RUT2,799−1.66%TNX5.10%+2.10%TYX5.43%+1.44%FVX4.95%+2.44%IRX4.13%+0.32%VIX18.70+6.92%GOLD$3,923.70+0.99%SILVER$50.54+0.95%OIL$88.24−0.56%DXY103.16−0.01%NVDA$166.19−4.34%AAPL$354.88−0.14%TSLA$397.45+1.70%META$623.61−0.82%MSFT$523.00+0.36%AMZN$267.44+0.48%GOOGL$298.70+1.79%Fear & Greed20 — Extreme FearADA$0.171−1.62%ETH$1,983−1.72%LINK$9.91−2.27%SOL$79.94−2.06%BTC$69,889−2.08%XRP$1.02−2.32%S&P 5007,592−0.35%Nasdaq25,366−0.39%Dow52,297−0.36%RUT2,799−1.66%TNX5.10%+2.10%TYX5.43%+1.44%FVX4.95%+2.44%IRX4.13%+0.32%VIX18.70+6.92%GOLD$3,923.70+0.99%SILVER$50.54+0.95%OIL$88.24−0.56%DXY103.16−0.01%NVDA$166.19−4.34%AAPL$354.88−0.14%TSLA$397.45+1.70%META$623.61−0.82%MSFT$523.00+0.36%AMZN$267.44+0.48%GOOGL$298.70+1.79%Fear & Greed20 — Extreme Fear

Tag

abbv

3 articles

U.S. Equities5d ago

AbbVie's Vraylar Heads for IRA Price Cut in 2027; Imbruvica Already Down 26 Percent

AbbVie warned investors to model lower prices for its $4.2 billion psychiatry drug Vraylar starting in 2027 under Medicare price negotiation, as its cancer drug Imbruvica faces a 26 percent sales cliff from IRA pricing.

U.S. Equities13d ago

AbbVie Raises FY Guidance on Skyrizi, Rinvoq Momentum

AbbVie beat Q3 EPS and revenue estimates, raising full-year adjusted EPS guidance to $13.95-$13.99 on strength in immunology franchises

U.S. Equities40d ago

AbbVie's Juvmo Approval Validates $8.7B Cerevel Bet, Eyes $1.4B Peak Sales

FDA approval of Juvmo, AbbVie's once-daily Parkinson's treatment, delivers near-term validation of its Cerevel acquisition and positions a new growth driver as Humira patent cliff deepens.